drugset / Trial / NCT00384891

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

NCT00384891

Phase 3 Terminated 190 enrolled Medical Enterprises Europe B.V.
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is designed to compare the efficacy and safety of 2 treatment types for the prevention of tumor recurrence of superficial bladder cancer: 1. A combination of bladder wall heating and local chemotherapy (Synergo) 2. Bacillus Calmette-Guérin (BCG)

Timeline

Start
2002-02
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bacillus Calmette-Guérin Vaccine Other